These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19070216)

  • 1. General properties of different models used to predict normal tissue complications due to radiation.
    Kuperman VY
    Med Phys; 2008 Nov; 35(11):4831-6. PubMed ID: 19070216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
    Luxton G; Keall PJ; King CR
    Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA; Li XA
    Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining the LKB NTCP model with radiosensitivity parameters to characterize toxicity of radionuclides based on a multiclonogen kidney model: a theoretical assessment.
    Lin H; Jing J; Xu L; Wu D; Xu Y
    Australas Phys Eng Sci Med; 2012 Jun; 35(2):165-76. PubMed ID: 22678954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
    Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
    Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
    Wennberg BM; Baumann P; Gagliardi G; Nyman J; Drugge N; Hoyer M; Traberg A; Nilsson K; Morhed E; Ekberg L; Wittgren L; Lund JÅ; Levin N; Sederholm C; Lewensohn R; Lax I
    Acta Oncol; 2011 May; 50(4):518-27. PubMed ID: 21198416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new formalism of Dose Surface Histograms for robust modeling of skin toxicity in radiation therapy.
    Palma G; Cella L
    Phys Med; 2019 Mar; 59():75-78. PubMed ID: 30928068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?
    Cella L; Palma G; Deasy JO; Oh JH; Liuzzi R; D'Avino V; Conson M; Pugliese N; Picardi M; Salvatore M; Pacelli R
    PLoS One; 2014; 9(10):e111753. PubMed ID: 25360627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
    Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
    Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
    Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy.
    De Marzi L; Feuvret L; Boulé T; Habrand JL; Martin F; Calugaru V; Fournier-Bidoz N; Ferrand R; Mazal A
    Br J Radiol; 2015 Apr; 88(1048):20140413. PubMed ID: 25671247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization.
    Zaider M; Amols HI
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):439-47. PubMed ID: 10760441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models.
    Takam R; Bezak E; Yeoh EE; Marcu L
    Med Phys; 2010 Sep; 37(9):5126-37. PubMed ID: 20964232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of normal-tissue complication probability models in the presence of confounding factors.
    Onjukka E; Baker C; Nahum A
    Med Phys; 2015 May; 42(5):2326-41. PubMed ID: 25979027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A little to a lot or a lot to a little: is NTCP always minimized in multiport therapy?
    Zaider M; Amols HI
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):945-50. PubMed ID: 9652862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic simulation of normal-tissue damage in radiotherapy--implications for dose-volume analyses.
    Rutkowska E; Baker C; Nahum A
    Phys Med Biol; 2010 Apr; 55(8):2121-36. PubMed ID: 20305336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response modeling and treatment plan assessment with a python software toolkit.
    Tzikas A; Lavdas E; Kechagias D; Mavroidis P
    Med Dosim; 2024 May; ():. PubMed ID: 38782687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.